Aspergillus fumigatus로 유발한 만성아토피피부염 동물모델 개발
Development of Aspergillus fumigatus-induced chronic atopic dermatitis mouse model
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Atopic dermatitis (AD) is the most common chronic and relapsing inflammatory skin disease with skin barrier defects and altered immune responses. Chronic inflammation leads to irreversible fibrosis in the skin and there is no treatment to completely abolish the inflammation and fibrosis. To prevent or treat the chronic process of AD, it is necessary to develop a murine model of AD that reflects the chronic process to identify the mechanism. The aims of this study were to develop a chronic AD model with a crude extract Aspergillus fumigatus (Af) antigen. Methods: We applied Af extract (40 μg) epicutaneously to the dorsal skin of BALB/c mice for 5 consecutive days per week during a period of 5 weeks for a chronic AD model, and 5 consecutive days repeatedly with 2 weeks interval for an acute AD model. Results: The clinical score and transepidermal water loss were more increased in the chronic AD model than in the acute AD model. Histologic findings showed that more increased epidermal thickness, neutrophil infiltration and hyperkeratosis in the chronic model than in the acute model. Skin fibrosis was more prominent in the chronic model than in the acute model. The mRNA expression levels of transforming growth factor (TGF)-β, thymic stromal lymphopoietin, and interleukin-33 were increased in the skin of the chronic model compared to the acute model. The levels of total IgE, Af-specific IgE, IgG1, and IgG2a were significantly increased in the chronic model compared to controls. Conclusion: The Af-induced chronic AD model showed prominent fibrosis and increased TGF-β expression in the skin, which suggests that these models may be useful in the research for the mechanism of the chronic process in AD.
Abstract
Purpose: Atopic dermatitis (AD) is the most common chronic and relapsing inflammatory skin disease with skin barrier defects and altered immune responses. Chronic inflammation leads to irreversible fibrosis in the skin and there is no treatment to completely abolish the inflammation and fibrosis. To prevent or treat the chronic process of AD, it is necessary to develop a murine model of AD that reflects the chronic process to identify the mechanism. The aims of this study were to develop a chronic AD model with a crude extract Aspergillus fumigatus (Af) antigen. Methods: We applied Af extract (40 μg) epicutaneously to the dorsal skin of BALB/c mice for 5 consecutive days per week during a period of 5 weeks for a chronic AD model, and 5 consecutive days repeatedly with 2 weeks interval for an acute AD model. Results: The clinical score and transepidermal water loss were more increased in the chronic AD model than in the acute AD model. Histologic findings showed that more increased epidermal thickness, neutrophil infiltration and hyperkeratosis in the chronic model than in the acute model. Skin fibrosis was more prominent in the chronic model than in the acute model. The mRNA expression levels of transforming growth factor (TGF)-β, thymic stromal lymphopoietin, and interleukin-33 were increased in the skin of the chronic model compared to the acute model. The levels of total IgE, Af-specific IgE, IgG1, and IgG2a were significantly increased in the chronic model compared to controls. Conclusion: The Af-induced chronic AD model showed prominent fibrosis and increased TGF-β expression in the skin, which suggests that these models may be useful in the research for the mechanism of the chronic process in AD.
참고문헌 (28)
- Dokmeci E, "The immune system and atopic dermatitis", Semin Cutan Med Surg, 27, pp.138~143 (2008)
- Spergel JM, "Atopic dermatitis and the atopic march", J Allergy Clin Immunol, 112(6 Suppl), pp.S118~S127 (2003)
- DaVeiga SP, "Epidemiology of atopic dermatitis: a review", Allergy Asthma Proc, 33, pp.227~234 (2012)
- Spergel JM, "Epidemiology of atopic dermatitis and atopic march in children", Immunol Allergy Clin North Am, 30, pp.269~280 (2010)
- Oyoshi MK, "Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis", Proc Natl Acad Sci U S A, 109, pp.4992~4997 (2012)
- Leung DY, "New insights into atopic dermatitis", J Clin Invest, 113, pp.651~657 (2004)
- Yu J, "Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism", PLoS One, 7, pp.e39032~ (2012)
- Breuer K, "Bacterial infections and atopic dermatitis", Allergy, 56, pp.1034~1041 (2001)
- de Meer G, "Early childhood environment related to microbial exposure and the occurrence of atopic disease at school age", Allergy, 60, pp.619~625 (2005)
- Ibargoyen-Roteta N, "Role of the home environment in rhinoconjunctivitis and eczema in schoolchildren in Pamplona, Spain", J Investig Allergol Clin Immunol, 17, pp.137~144 (2007)
- Miyake Y, "Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study", Pediatr Allergy Immunol, 18, pp.425~432 (2007)
- Reponen T, "Infant origins of childhood asthma associated with specific molds", J Allergy Clin Immunol, 130, pp.639~644.e5 (2012)
- Akei HS, "Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses", J Allergy Clin Immunol, 118, pp.62~69 (2006)
- Matsushima H, "Skin scratching switches immune responses from Th2 to Th1 type in epicutaneously immunized mice", J Dermatol Sci, 32, pp.223~230 (2003)
- Heratizadeh A, "Adaptive immune response and associated trigger factors in atopic dermatitis", Hautarzt, 66, pp.96~102 (2015)
- Batista DI, "Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1", Th2, J Eur Acad Dermatol Venereol, pp.2015, 29[DOI]
- Dhingra N, "A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis", J Invest Dermatol, 134, pp.2071~2074 (2014)
- Toda M, "Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions", J Allergy Clin Immunol, 111, pp.875~881 (2003)
- Ishida Y, "Es- sential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration", Am J Pathol, 170, pp.843~854 (2007)
- Oh MH, "IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin", J Im- munol, 186, pp.7232~7242 (2011)
- Zheng T, "Transgenic ex- pression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling", J Invest Dermatol, 129, pp.742~751 (2009)
- Jessup HK, "Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response", J Immunol, 181, pp.4311~4319 (2008)
- McHedlidze T, "Interleukin-33-dependent innate lymphoid cells mediate hepatic fi- brosis", Immunity, 39, pp.357~371 (2013)
- Salimi M, "A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis", J Exp Med, 210, pp.2939~2950 (2013)
- Kim BS, "TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation", Sci Transl Med, 5(170ra16) (2013)
- Hams E, "IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis", Proc Natl Acad Sci U S A, 111, pp.367~372 (2014)
- Imai Y, "Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice", Proc Natl Acad Sci U S A, 110, pp.13921~13926 (2013)
- Kim RY, "Elucidating novel disease mechanisms in severe asthma", Clin Transl Im- munology, 5, pp.e91~ (2016)